Ro / Roman: the care and the offer

Name the option within the service

Ro's ED page presents branded and generic tablet options as well as Ro Sparks and Daily Rise Gummies. The latter products are described as compounded and not FDA-approved. A reader comparing “Roman versus another provider” therefore needs one more level of detail: the exact proposed product and the care arrangement attached to it. [Ro]

This directory does not assign Ro a single universal price. The public offer contains promotion and plan conditions, and the amount depends on the selected treatment. Write down the product, quantity, payment term and post-promotion charge before comparing it with a bottle pack or another service's per-pill figure.

Ask which evidence applies

FDA approval of a branded or generic medicine does not extend to a separately compounded formulation containing its ingredient. If the proposal is Sparks or a gummy, ask the clinician why that formulation is appropriate and what is known about that particular product. Our compounding guide applies the same evidence standard to Ro, 4Play and other multi-ingredient offers. [FDA]

Look beyond access to the first prescription

Find out whether the assessment is conducted by messages, video or another method in your state, and how the team handles questions that require an examination. NIDDK describes history, examination and possible testing as parts of ED diagnosis. A convenient starting point does not establish that every symptom or cause can be resolved online. [NIDDK]

Before enrolling, confirm the renewal terms, clinician contact route and what happens if treatment is not prescribed. Retain the plan-specific information you receive. We have not tested Ro's response times, delivery or clinical outcomes, so this profile does not grade those experiences. Use the preparation guide to organize the questions that depend on your own history rather than the website's product menu.